IBX vs IMR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

44LOW

IMR

IMRICOR CDI FORUS [IMR]

44LOW

Score Breakdown

IBX IMR
Technical
61
69
Catalyst
50
50
Sentiment
50
50
Fundamental
11
55
Momentum
62
58
Risk Gate
37
45

Key Metrics

IBX Metric IMR
$10.3MMarket Cap$635.5M
2.0MAvg Volume (20d)374K
N/AShort Interest+0.0%
$0.05552-Week High$2.250
$0.01152-Week Low$1.115
+22.2%Daily Change+5.7%
$0.022Entry Price$1.945
N/AROE-1221.3%
N/AProfit MarginN/A

Active Signals

IBX Signals

●MACD just crossed bullish — momentum is shifting to the upside
●Above-average volume (1.8x) on a green day — buyers stepping up
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 15.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●4C filed 2026-01-28
●Very high P/S ratio (141.1x)

IMR Signals

●Volume surging at 2.7x normal while price climbs — real buying conviction behind this move
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)
●Very high P/S ratio (2174.0x)
●Revenue in sharp decline (-83%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●CANSLIM I: Institutional ownership (18%)
●Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare IBX and IMR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IBX Full Analysis → IMR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).